Skip to main content

Marrow Grafting for Leukemia

  • Chapter
  • 10 Accesses

Part of the book series: Experimental Hematology ((HEMATOLOGY))

Abstract

Until 1975, marrow grafting following high-dose chemotherapy combined with total body irradiation (TBI) was considered only for patients with acute leukemia in advanced relapse when all other therapy had failed. 110 such patients were given marrow grafts from HLA-identical siblings in Seattle, and 10% are alive in unmaintained remission between 9 and 14 years without further treatment (1). Even though many patients died from graft-versus-host disease (GVHO). interstitial pneumonias and other infections, it was clear that leukemic relapse was a major complication after marrow grafting, occurring at an actuarial rate of 75% (2). As far as could be determined, leukemic recurrences usually originated from host cells which were apparently resistant to the high-dose chemoradiotherapy used to prepare the patients for transplantation. This was true both for patients with acute lymphoblastic (ALL) and acute non-lymphoblastic leukemia (ANL) in advanced relapse.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511–533, 1977.

    CAS  PubMed  Google Scholar 

  2. Thomas ED, Flournoy N, Buckner CD, et al. Cure of leukemia by marrow transplantation. Leukemia Research 1: 67–70, 1977.

    Article  Google Scholar 

  3. Appelbaum FR, Clift RA, Buckner CD, et al. Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 61: 949–953, 1983.

    CAS  PubMed  Google Scholar 

  4. Thomas ED, Buckner CD, Clift RA, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301: 597–599, 1979.

    Article  CAS  PubMed  Google Scholar 

  5. Appelbaum FR, Dahlberg S, Thomas ED, et al. Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia–A prospective comparison. Ann Intern Med 101: 581–588, 1984.

    Article  CAS  PubMed  Google Scholar 

  6. Thomas ED, Sanders JE, Flournoy N, et al. Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54: 468–476, 1979.

    CAS  PubMed  Google Scholar 

  7. Sanders JE, Flournoy N, Thomas EU, et al. Marrow transplant experience in children with acute lymphoblastic leukemia: An analysis of factors associated with survival, relapse and graft-versus-host disease. Med Pediatr Oncol, in press.

    Google Scholar 

  8. Johnson FL, Thomas ED, Clark BS, et al. A comparison of marrow transplantation to chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med 305: 846–851, 1981.

    Article  CAS  PubMed  Google Scholar 

  9. Storb R. Marrow transplantation for the treatment of malignant diseases. In: Progress in Transplantation, Vol. 1, Morris PJ, Tilney N (eds). London: Churchill Livingstone, 1984, pp 46–70.

    Google Scholar 

  10. Fefer A, Cheever MA, Greenberg PD, et al. Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. N Engl J Med 306: 63–68, 1982.

    Article  CAS  PubMed  Google Scholar 

  11. Clift RA, Buckner CD, Thomas ED, et al. The treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet 2: 227–228, 1982.

    PubMed  Google Scholar 

  12. Deeg HJ, Storb R, Thomas ED, et al. Cyclosporine as prophylaxis for graft-versus-host disease: A randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood, 1984, in press.

    Google Scholar 

  13. Storb R, Deeg HJ, Thomas ED, et al. Marrow transplantation for chronic myelocytic leukemia: A controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. Blood, in press.

    Google Scholar 

  14. Martin PJ, Hansen JA, Storb R, et al. A clinical trial of in vitro depletion of T cells in donor marrow for prevention of acute graft-versus-host disease (GVHD). Transplant Proc, in press.

    Google Scholar 

  15. Clift RA, Beatty PG, Thomas ED, et al. Marrow transplantation from mismatched donors for the treatment of malignancy. Transplant Proc, in press.

    Google Scholar 

  16. Clift RA, Hansen JA, Thomas ED, et al. Marrow transplantation from donors other than HLA-identical siblings. Transplantation 28: 235–242, 1979.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer Science+Business Media New York

About this chapter

Cite this chapter

Storb, R. (1985). Marrow Grafting for Leukemia. In: Hinterberger, W., Barrett, A.J., Lechner, K., Deutsch, E. (eds) 11th Annual meeting of the EBMT. Experimental Hematology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-40457-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-40457-7_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-39399-4

  • Online ISBN: 978-3-662-40457-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics